GeneDx Holdings (WGS) Cash from operations

annual CFO:

-$28.50M+$151.65M(+84.18%)
December 31, 2024

Summary

  • As of today (May 29, 2025), WGS annual cash flow from operations is -$28.50 million, with the most recent change of +$151.65 million (+84.18%) on December 31, 2024.
  • During the last 3 years, WGS annual CFO has risen by +$161.94 million (+85.04%).
  • WGS annual CFO is now -52.16% below its all-time high of -$18.73 million, reached on December 1, 2019.

Performance

WGS Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGScash flow metrics

quarterly CFO:

$10.18M+$13.37M(+419.89%)
March 31, 2025

Summary

  • As of today (May 29, 2025), WGS quarterly cash flow from operations is $10.18 million, with the most recent change of +$13.37 million (+419.89%) on March 31, 2025.
  • Over the past year, WGS quarterly CFO has increased by +$26.59 million (+162.04%).
  • WGS quarterly CFO is now at all-time high.

Performance

WGS quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGScash flow metrics

TTM CFO:

-$1.90M+$26.59M(+93.33%)
March 31, 2025

Summary

  • As of today (May 29, 2025), WGS TTM cash flow from operations is -$1.90 million, with the most recent change of +$26.59 million (+93.33%) on March 31, 2025.
  • Over the past year, WGS TTM CFO has increased by +$139.10 million (+98.65%).
  • WGS TTM CFO is now at all-time high.

Performance

WGS TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGScash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

WGS Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+84.2%+162.0%+98.7%
3 y3 years+85.0%+112.5%+99.2%
5 y5 years-52.2%--

WGS Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+91.1%at high+111.5%at high+99.4%
5 y5-year-52.2%+91.1%at high+111.5%at high+99.4%
alltimeall time-52.2%+91.1%at high+111.5%at high+99.4%

WGS Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
$10.18M(-419.9%)
-$1.90M(-93.3%)
Dec 2024
-$28.50M(-84.2%)
-$3.18M(-27.6%)
-$28.50M(-48.3%)
Sep 2024
-
-$4.39M(-2.4%)
-$55.17M(-40.0%)
Jun 2024
-
-$4.50M(-72.6%)
-$92.00M(-34.7%)
Mar 2024
-
-$16.41M(-45.0%)
-$141.00M(-21.7%)
Dec 2023
-$180.15M(-43.6%)
-$29.86M(-27.6%)
-$180.15M(-16.2%)
Sep 2023
-
-$41.23M(-22.9%)
-$214.94M(-18.0%)
Jun 2023
-
-$53.50M(-3.7%)
-$262.08M(-10.6%)
Mar 2023
-
-$55.56M(-14.1%)
-$293.22M(-8.1%)
Dec 2022
-$319.15M
-$64.65M(-26.8%)
-$319.15M(+4.1%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$88.36M(+4.4%)
-$306.49M(+6.0%)
Jun 2022
-
-$84.64M(+3.9%)
-$289.06M(+25.8%)
Mar 2022
-
-$81.49M(+56.8%)
-$229.72M(+20.6%)
Dec 2021
-$190.43M(+104.5%)
-
-
Dec 2021
-
-$51.98M(-26.7%)
-$190.43M(+37.5%)
Sep 2021
-
-$70.94M(+180.4%)
-$138.45M(+105.1%)
Jun 2021
-
-$25.30M(-40.1%)
-$67.51M(+59.9%)
Mar 2021
-
-$42.21M
-$42.21M
Dec 2020
-$93.13M(+397.3%)
-
-
Dec 2019
-$18.73M
-
-

FAQ

  • What is GeneDx Holdings annual cash flow from operations?
  • What is the all time high annual CFO for GeneDx Holdings?
  • What is GeneDx Holdings annual CFO year-on-year change?
  • What is GeneDx Holdings quarterly cash flow from operations?
  • What is the all time high quarterly CFO for GeneDx Holdings?
  • What is GeneDx Holdings quarterly CFO year-on-year change?
  • What is GeneDx Holdings TTM cash flow from operations?
  • What is the all time high TTM CFO for GeneDx Holdings?
  • What is GeneDx Holdings TTM CFO year-on-year change?

What is GeneDx Holdings annual cash flow from operations?

The current annual CFO of WGS is -$28.50M

What is the all time high annual CFO for GeneDx Holdings?

GeneDx Holdings all-time high annual cash flow from operations is -$18.73M

What is GeneDx Holdings annual CFO year-on-year change?

Over the past year, WGS annual cash flow from operations has changed by +$151.65M (+84.18%)

What is GeneDx Holdings quarterly cash flow from operations?

The current quarterly CFO of WGS is $10.18M

What is the all time high quarterly CFO for GeneDx Holdings?

GeneDx Holdings all-time high quarterly cash flow from operations is $10.18M

What is GeneDx Holdings quarterly CFO year-on-year change?

Over the past year, WGS quarterly cash flow from operations has changed by +$26.59M (+162.04%)

What is GeneDx Holdings TTM cash flow from operations?

The current TTM CFO of WGS is -$1.90M

What is the all time high TTM CFO for GeneDx Holdings?

GeneDx Holdings all-time high TTM cash flow from operations is -$1.90M

What is GeneDx Holdings TTM CFO year-on-year change?

Over the past year, WGS TTM cash flow from operations has changed by +$139.10M (+98.65%)
On this page